Cellular action of nicardipine

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Neuroscience

Background:

• Nicardipine is a dihydropyridine calcium antagonist used for angina and hypertension.
• It exhibits high affinity for dihydropyridine binding sites and inhibits L-type calcium channels.

Purpose of the Study:

• To investigate the mechanisms underlying nicardipine's efficacy in treating cerebral and myocardial ischemia.
• To examine proposed actions such as membrane stabilization, sodium channel blockade, cellular concentration, and mitochondrial calcium efflux.

Main Methods:

• Assessed nicardipine's inhibitory effects on calcium ion-dependent action potentials in ventricular papillary muscle.
• Quantified nicardipine's potency in inhibiting vascular smooth muscle responses.
• Investigated potential cellular accumulation of nicardipine in ischemic cells.

Main Results:

• Nicardipine demonstrated dose-dependent inhibition of calcium ion-dependent action potentials (pIC50 = 7.15).
• It showed greater potency in inhibiting vascular smooth muscle (pIC50 = 8.20) compared to cardiac muscle.
• The hypothesis of nicardipine concentrating in ischemic cells due to its tertiary amine structure was not conclusively demonstrated.

Conclusions:

• Nicardipine's selectivity for vascular smooth muscle contributes to its efficacy in treating angina and hypertension.
• Further research is needed to fully elucidate the mechanisms of nicardipine's beneficial effects in ischemic conditions.
• The proposed mechanisms, including membrane stabilization and ion channel modulation, warrant continued investigation.